Medical Consumables
Capital Equipment
Brands
LUMOS

FebriDx Point-of-Care Test - 25 Strips - Single

Product Code : LU-CP0041

Description

FebriDx point-of-care test device

FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial and viral infection.

Knowing whether a patient has a bacterial infection has a direct impact on reducing unnecessary antibiotic prescriptions, limiting the spread of antibiotic-resistant bacteria, and helping providers know when to initiate treatment.

  • Results after 10 minutes increases confidence in whether or not to prescribe an antibiotic
  • Highly sensitive/specific dual biomarker technology provides reliable differentiation of bacterial and non-bacterial (viral) infections
  • All-in-one, instrument-free test device means no expensive equipment and a fully portable solution

Benefits Of FebriDX
  • Increase confidence in decision making - Confidently rule out a bacterial infection with 99% negative predictive value (NPV)
  • Ensure bacterial infections are not overlooked - Increased confidence in patient diagnosis
  • Improve patient satisfaction - Support patient understanding of treatment plan with a tangible test result
  • Enable improved patient management - Actionable results after 10 minutes for use during a patient visit
  • Support antimicrobial stewardship - Reduce unnecessary antibiotic useBacterial or viral infection?


Bacterial or Viral Infection

The symptoms can be very similar.

Acute respiratory infections, causing symptoms such as common cold, sore throat, cough, congestion and runny nose, are the most common reason for seeking medical advice and antibiotic prescriptions.Differentiating between bacterial infection and non-bacterial etiology can be challenging due to an overlap in signs and symptoms of bacterial and non-bacterial infections.
The majority of acute respiratory infections are caused by viruses and do not require antibiotics, yet antibiotics are prescribed inappropriately in up to 50% of cases. Antibiotic resistance is a major global health threat contributing to hundreds of thousands of deaths globally.
Patients with viral infections should be cohorted appropriately in order to reduce the spread of infection. Accurate detection of a viral infection can help prioritize which patients should have pathogen-specific testing performed.
Technical Specifications
Brand LUMOS